急性心肌梗死伴非阻塞性冠状动脉患者的侵入性激发试验安全性与预后价值
本研究前瞻性纳入80例确诊MINOCA且排除其他病因的患者,在冠脉造影后行乙酰胆碱或麦角新碱激发试验,随访中位36个月。激发试验阳性者全因死亡、心源性死亡及ACS再入院风险均显著更高,且心绞痛状态更差;试验未发生并发症。
要点
- MINOCA患者行乙酰胆碱或麦角新碱激发试验安全无并发症。
- 激发试验阳性者全因死亡和心源性死亡风险显著升高。
- 阳性者ACS再入院更多且心绞痛状态更差,属高危亚组。
核心结论
- 在MINOCA且疑诊冠状动脉血管运动异常的患者中,激发试验阳性安全且可识别高危亚组。
研究设计与样本
- 前瞻性研究连续纳入80例MINOCA患者,排除其他病因后行乙酰胆碱或麦角新碱侵入性激发试验。
主要发现
- 激发试验阳性37例(46.2%),其中心外膜痉挛24例(64.9%)、微血管痉挛13例(35.1%),均无并发症。
- 中位随访36.0个月,阳性组全因死亡12例(32.4%) vs 2例(4.7%),P=0.002。
- 阳性组心源性死亡7例(18.9%) vs 0例(0.0%),P=0.005。
- 阳性组ACS再入院10例(27.0%) vs 3例(7.0%),P=0.015。
- 阳性组西雅图心绞痛问卷评分88.0(33.0-100.0) vs 100.0(44.0-100.0),P=0.001。
临床怎么用
- 对MINOCA且疑诊冠状动脉血管运动异常者,可考虑行乙酰胆碱或麦角新碱激发试验以识别高危患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Functional alterations of epicardial coronary arteries or coronary microcirculation represent a frequent cause of myocardial infarction and non-obstructive coronary arteries (MINOCA). We aimed at assessing the prognostic value of intracoronary provocative tests in patients presenting with MINOCA and in which other causes of MINOCA have been excluded. METHODS AND RESULTS: We prospectively evaluated patients with a diagnosis of MINOCA, excluding patients with aetiologies other than suspected coronary vasomotor abnormalities. Immediately after coronary angiography, an invasive provocative test using acetylcholine or ergonovine was performed. The incidence of death from any cause, cardiac death, and recurrence of acute coronary syndrome (ACS) was assessed at follow-up. We also assessed angina status using Seattle Angina Questionnaires (SAQ). We enrolled 80 consecutive patients [mean age 63.0 ± 10.7 years, 40 (50%) male]. Provocative test was positive in 37 (46.2%) patients without any complication. Among patients with a positive test, epicardial spasm was detected in 24 (64.9%) patients and microvascular spasm in 13 (35.1%) patients. After a median follow-up of 36.0 (range 12.0-60.0) months, patients with a positive test had a significantly higher occurrence of death from any cause [12 (32.4%) vs. 2 (4.7%); P = 0.002], cardiac death [7 (18.9%) vs. 0 (0.0%); P = 0.005], and readmission for ACS [10 (27.0%) vs. 3 (7.0%); P = 0.015] as well as a worse angina status as assessed by SAQ [Seattle score: 88.0 (33.0-100.0) vs. 100.0 (44.0-100.0); P = 0.001] when compared with patients with a negative test. CONCLUSIONS: We demonstrate that in patients presenting with MINOCA and suspected coronary vasomotor abnormalities, a positive provocative test for spasm is safe and identifies a high-risk subset of patients.
引用
- Montone RA, Niccoli G, Fracassi F, et al. Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests. Eur Heart J. 2018. PMID: 29228159. doi:10.1093/eurheartj/ehx667
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。